Skip to main content
Smart Investors Daily
NA

NASDAQ · NAII

Natural Alternatives International, Inc.

Consumer Defensive · Packaged Foods

$2.04

Down-$0.13 (-5.99%)

Updated Aug 15, 2026, 10:27 AM

SID Score

2.8/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
19.89M
P/E ratio
-1.47
Dividend yield
0.00%
52-week range
$2.01 – $3.35
Volume
17.72K
Avg. volume
23.71K

Price performance

NAII price history

1M range · 21 trading sessions · Daily adjusted prices

NAII closed at $2.04 after 21 trading sessions, down 8.11% for the selected period.

Last close
$2.04
Period change
-8.11%
Period low
$2.04
Period high
$2.43
Daily close
View OHLC price history
NAII OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 14, 2026$2.2688$2.27$2.01$2.0417.72K
Aug 13, 2026$2.06$2.21$2.06$2.1720.41K
Aug 12, 2026$2.0734$2.2386$2.035$2.1024.22K
Aug 11, 2026$2.09$2.37$2.05$2.181.35M
Aug 10, 2026$2.29$2.33$2.27$2.331.63K
Aug 7, 2026$2.39$2.39$2.31$2.36994.35K
Aug 6, 2026$2.26$2.445$2.25$2.381.29K
Aug 5, 2026$2.30$2.35$2.24$2.2626.47K
Aug 4, 2026$2.29$2.35$2.26$2.327.9K
Aug 3, 2026$2.39$2.39$2.26$2.277.79K
Jul 31, 2026$2.45$2.45$2.29$2.292.32K
Jul 30, 2026$2.22$2.475$2.22$2.426236.98K
Jul 29, 2026$2.41$2.45$2.20$2.2212.55K
Jul 28, 2026$2.5296$2.5296$2.35$2.355.46K
Jul 27, 2026$2.55$2.55$2.36$2.377.96K
Jul 24, 2026$2.32$2.40$2.31$2.405.1K
Jul 23, 2026$2.33$2.40$2.32$2.322.73K
Jul 22, 2026$2.31$2.49$2.30$2.3815.78K
Jul 21, 2026$2.23$2.37$2.20$2.3535.93K
Jul 20, 2026$2.27$2.37$2.085$2.157.67K
Jul 17, 2026$2.21$2.25$2.21$2.227.17K

Latest NAII news

The latest Smart Investors Daily articles mentioning NAII.

NAII research

Overview

Company profile and research snapshot.

Company profile

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.